MMedication Read More A New King of The GLP-1s Could Be Crowned – Cardiac WireOctober 5, 2026 A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
MMedication Read More Doctors condemn Eli Lilly move to dispense GLP-1 medication Mounjaro direct to doorSeptember 30, 2026 A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…
MMedication Read More Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision lossSeptember 23, 2026 PHOENIX (AZFamily/Gray News) — Hundreds of lawsuits have been filed against major GLP-1 makers Eli Lilly and Novo…
MMedication Read More Hundreds of lawsuits filed against some GLP-1 Makers over vision lossSeptember 22, 2026 Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
MMedication Read More Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo FinanceSeptember 21, 2026 Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
EEconomy Read More Novo cuts 13,000 jobs in a year – The Irish TimesSeptember 21, 2026 Novo said on Monday it had cut its workforce by 13,000 in the past year as the maker…
UUnited Kingdom Read More Lilly Launches Foundayo in the UK as NICE Review ContinuesSeptember 5, 2026 Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country…
HHealthcare Read More Eli Lilly’s (LLY) Growth Story Keeps Adding ChaptersAugust 18, 2026 On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days…
MMedication Read More Eli Lilly CEO still wants deal to bring Mounjaro to Australia under PBSAugust 12, 2026 Eli Lilly pharmaceuticals CEO David Ricks says he still wants to reach an agreement with the Australian government…
MMedication Read More Semaglutide Generics Surge in Sales Despite Supply Challenges, ETPharmaAugust 8, 2026 New Delhi: After a brief slowdown, sales of generic versions of the weight-loss drug semaglutide recorded a strong…
MMedication Read More Will Mounjaro & Zepbound Drive Lilly’s Q2 Results: Buy, Sell or Hold?August 4, 2026 Eli Lilly and Company LLY will report its second-quarter 2026 earnings on Aug. 5, before market open. The Zacks…
MMedication Read More ‘Super weight loss’ drug retatrutide could be available soonJuly 29, 2026 KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…